{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T16:09:37Z","timestamp":1790784577304,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/j.clim.2016.09.007","type":"journal-article","created":{"date-parts":[[2016,9,19]],"date-time":"2016-09-19T17:17:18Z","timestamp":1474305438000},"page":"96-108","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction \u2014 A comparative study"],"prefix":"10.1016","volume":"173","author":[{"given":"Endy","family":"Adnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Suemori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Yasukawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3902-2066","authenticated-orcid":false,"given":"Hitoshi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clim.2016.09.007_bb0005","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3389\/fimmu.2013.00082","article-title":"Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells","volume":"4","author":"Hubo","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0010","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.autrev.2014.10.010","article-title":"Role of dendritic cells in the initiation, progress and modulation of systemic autoimmune diseases","volume":"14","author":"Mackern-Oberti","year":"2015","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.09.007_bb0015","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.autrev.2010.07.015","article-title":"Tolerogenic dendritic cells in autoimmune diseases: crucial players in induction and prevention of autoimmunity","volume":"10","author":"Torres-Aguilar","year":"2010","journal-title":"Autoimmun. Rev."},{"key":"10.1016\/j.clim.2016.09.007_bb0020","doi-asserted-by":"crossref","first-page":"123","DOI":"10.3389\/fimmu.2012.00123","article-title":"Therapeutic potential of semi-mature dendritic cells for tolerance induction","volume":"3","author":"Lutz","year":"2012","journal-title":"Front. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0025","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1189\/jlb.0613336","article-title":"Tolerogenic dendritic cells: molecular and cellular mechanisms in transplantation","volume":"95","author":"Svajger","year":"2014","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2016.09.007_bb0030","doi-asserted-by":"crossref","first-page":"16381","DOI":"10.3390\/ijms150916381","article-title":"Targeting dendritic cell function during systemic autoimmunity to restore tolerance","volume":"15","author":"Mackern-Oberti","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.clim.2016.09.007_bb0035","doi-asserted-by":"crossref","first-page":"2026","DOI":"10.2337\/dc11-0472","article-title":"Phase I (safety) study of autologous tolerogenic dendritic cells in type 1 diabetic patients","volume":"34","author":"Giannoukakis","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.clim.2016.09.007_bb0040","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/db13-0886","article-title":"It's time to bring dendritic cell therapy to type 1 diabetes","volume":"63","author":"Creusot","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/j.clim.2016.09.007_bb0045","article-title":"Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis","author":"Bell","year":"2016","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2016.09.007_bb0050","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaa9301","article-title":"Citrullinated peptide dendritic cell immunotherapy in HLA risk genotype-positive rheumatoid arthritis patients","volume":"7","author":"Benham","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.clim.2016.09.007_bb0055","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3109\/08830185.2010.522280","article-title":"Novel findings in drug-induced dendritic cell tolerogenicity","volume":"29","author":"Svajger","year":"2010","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0060","doi-asserted-by":"crossref","first-page":"6473","DOI":"10.4049\/jimmunol.162.11.6473","article-title":"Glucocorticoids affect human dendritic cell differentiation and maturation","volume":"162","author":"Piemonti","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0065","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-3083.2005.01640.x","article-title":"Dexamethasone induces IL-10-producing monocyte-derived dendritic cells with durable immaturity","volume":"62","author":"Xia","year":"2005","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0070","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1002\/eji.200839103","article-title":"Induction of Treg by monocyte-derived DC modulated by vitamin D3 or dexamethasone: differential role for PD-L1","volume":"39","author":"Unger","year":"2009","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0075","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.4049\/jimmunol.164.5.2405","article-title":"1Alpha, 25-dihydroxyvitamin D3 inhibits differentiation, maturation, activation, and survival of dendritic cells leading to impaired alloreactive T cell activation","volume":"164","author":"Penna","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0080","doi-asserted-by":"crossref","first-page":"4443","DOI":"10.4049\/jimmunol.164.9.4443","article-title":"Vitamin D3 affects differentiation, maturation, and function of human monocyte-derived dendritic cells","volume":"164","author":"Piemonti","year":"2000","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0085","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.transproceed.2006.12.032","article-title":"Generation of dendritic cells with regulatory properties","volume":"39","author":"Ureta","year":"2007","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.clim.2016.09.007_bb0090","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1002\/1521-4141(2001010)31:10<2857::AID-IMMU2857>3.0.CO;2-X","article-title":"Peroxisome proliferator-activated receptor gamma activators affect the maturation of human monocyte-derived dendritic cells","volume":"31","author":"Gosset","year":"2001","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0095","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.4049\/jimmunol.178.4.2122","article-title":"Peroxisome proliferator-activated receptor gamma control of dendritic cell function contributes to development of CD4+ T cell anergy","volume":"178","author":"Klotz","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0100","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1111\/sji.12039","article-title":"Type 1 regulatory T cells and regulatory B cells induced by tolerogenic dendritic cells","volume":"77","author":"Volchenkov","year":"2013","journal-title":"Scand. J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0105","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/mi.2014.64","article-title":"Retinoic acid primes human dendritic cells to induce gut-homing, IL-10-producing regulatory T cells","volume":"8","author":"Bakdash","year":"2015","journal-title":"Mucosal. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0110","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/cei.12177","article-title":"Retinoic acid-producing, ex-vivo-generated human tolerogenic dendritic cells induce the proliferation of immunosuppressive B lymphocytes","volume":"174","author":"Di Caro","year":"2013","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0115","doi-asserted-by":"crossref","first-page":"4772","DOI":"10.4049\/jimmunol.159.10.4772","article-title":"Induction of tolerance by IL-10-treated dendritic cells","volume":"159","author":"Steinbrink","year":"1997","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0120","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S0008-8749(02)00007-2","article-title":"IL-10 alters DC function via modulation of cell surface molecules resulting in impaired T-cell responses","volume":"215","author":"Mcbride","year":"2002","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0125","doi-asserted-by":"crossref","first-page":"3581","DOI":"10.1182\/blood-2002-09-2712","article-title":"Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells","volume":"101","author":"Sato","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.09.007_bb0130","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.4049\/jimmunol.0902133","article-title":"Tolerogenic dendritic cells generated with different immunosuppressive cytokines induce antigen-specific anergy and regulatory properties in memory CD4+ T cells","volume":"184","author":"Torres-Aguilar","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0135","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1182\/blood-2006-10-050583","article-title":"TGF-\u03b2 combined with M-CSF and IL-4 induces generation of immune inhibitory cord blood dendritic cells capable of enhancing cytokine-induced ex vivo expansion of myeloid progenitors","volume":"110","author":"Li","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.09.007_bb0140","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.intimp.2007.07.003","article-title":"Physiological concentrations of transforming growth factor \u03b21 selectively inhibit human dendritic cell function","volume":"7","author":"Fogel-Petrovic","year":"2007","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.clim.2016.09.007_bb0145","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1097\/00007890-200301150-00025","article-title":"Rapamycin impairs antigen uptake of human dendritic cells","volume":"75","author":"Monti","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2016.09.007_bb0150","doi-asserted-by":"crossref","first-page":"7018","DOI":"10.4049\/jimmunol.178.11.7018","article-title":"Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific Foxp3+ T regulatory cells and promote organ transplant tolerance","volume":"178","author":"Turnquist","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0155","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.imlet.2008.06.009","article-title":"Rapamycin downregulates the inhibitory receptors ILT2, ILT3, ILT4 on human dendritic cells and yet induces T cell hyporesponsiveness independent of Foxp3 induction","volume":"120","author":"Fedoric","year":"2008","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.clim.2016.09.007_bb0160","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.4049\/jimmunol.1203053","article-title":"Protein kinase C inhibitor generates stable human tolerogenic dendritic cells","volume":"191","author":"Matsumoto","year":"2013","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0165","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1136\/ard.2009.126383","article-title":"Generation and characterization of therapeutic tolerogenic dendritic cells for rheumatoid arthritis","volume":"69","author":"Harry","year":"2010","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2016.09.007_bb0170","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/1479-5876-9-89","article-title":"Comparative study of clinical grade human tolerogenic dendritic cells","volume":"9","author":"Naranjo-Gomez","year":"2011","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.clim.2016.09.007_bb0175","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.clim.2011.11.011","article-title":"IL-10-generated tolerogenic dendritic cells are optimal for functional regulatory T cell induction \u2014 a comparative study of human clinical-applicable DC","volume":"142","author":"Boks","year":"2012","journal-title":"Clin. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0180","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1002\/art.27584","article-title":"2010 rheumatoid arthritis classification criteria: an American college of rheumatology\/European league against rheumatism collaborative initiative","volume":"62","author":"Aletaha","year":"2010","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.clim.2016.09.007_bb0185","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1136\/ard.61.6.554","article-title":"European study group on classification criteria for Sj\u00f6gren's syndrome, classification criteria for Sj\u00f6gren's syndrome: a revised version of the European criteria proposed by the American\u2013European consensus group","volume":"61","author":"Vitali","year":"2002","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.clim.2016.09.007_bb0190","doi-asserted-by":"crossref","first-page":"7186","DOI":"10.4049\/jimmunol.1001437","article-title":"Peroxisome proliferator-activated receptor \u03b1 and \u03b3 agonists together with TGF-\u03b2 convert human CD4+CD25\u2212 T cells into functional Foxp3+ regulatory T cells","volume":"185","author":"Lei","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0195","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1189\/jlb.1208733","article-title":"PPARgamma regulates retinoic acid-mediated DC induction of Tregs","volume":"86","author":"Housley","year":"2009","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.clim.2016.09.007_bb0200","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1038\/nri2297","article-title":"CCR7 and its ligands: balancing immunity and tolerance","volume":"8","author":"Forster","year":"2008","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0205","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1097\/01.tp.0000235433.03554.4f","article-title":"Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin","volume":"82","author":"Sordi","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.clim.2016.09.007_bb0210","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/ni.1603","article-title":"Phosphatidylinositol-3-OH kinase and nutrient-sensing mTOR pathways control T lymphocyte trafficking","volume":"9","author":"Sinclair","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0215","doi-asserted-by":"crossref","first-page":"3865","DOI":"10.4049\/jimmunol.162.7.3865","volume":"162","author":"Sato","year":"1999","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0220","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1038\/leu.2008.301","article-title":"Post-transcriptional regulation of adapter molecules by IL-10 inhibits TLR-mediated activation of antigen-presenting cells","volume":"23","author":"Kn\u00f6dler","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clim.2016.09.007_bb0225","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.coph.2006.01.010","article-title":"Understanding and exploiting the endogenous interleukin-10\/STAT3-mediated anti-inflammatory response","volume":"6","author":"Murray","year":"2006","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.clim.2016.09.007_bb0230","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1067\/mai.2003.97","article-title":"Update on glucocorticoid action and resistance","volume":"111","author":"Leung","year":"2003","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0235","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4049\/jimmunol.178.1.145","article-title":"1,25-Dihydroxyvitamin D3 selectively modulates tolerogenic properties in myeloid but not plasmacytoid dendritic cells","volume":"178","author":"Penna","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.clim.2016.09.007_bb0240","doi-asserted-by":"crossref","first-page":"4457","DOI":"10.1182\/blood-2002-11-3370","article-title":"Rapamycin inhibits IL-4\u2013induced dendritic cell maturation in vitro and dendritic cell mobilization and function in vivo","volume":"101","author":"Hackstein","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clim.2016.09.007_bb0245","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1016\/j.bcp.2006.07.030","article-title":"15-deoxy-delta12,14-prostaglandin J2 as a potential endogenous regulator of redox-sensitive transcription factors","volume":"72","author":"Kim","year":"2006","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.clim.2016.09.007_bb0250","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.bcp.2011.07.100","article-title":"15-Deoxy-\u039412,14-prostaglandin J2, an electrophilic lipid mediator of anti-inflammatory and pro-resolving signaling","volume":"82","author":"Surh","year":"2011","journal-title":"Biochem. Pharmacol."}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616303916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521661616303916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T13:00:09Z","timestamp":1718802009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521661616303916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":50,"alternative-id":["S1521661616303916"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2016.09.007","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Human tolerogenic dendritic cells generated with protein kinase C inhibitor are optimal for functional regulatory T cell induction \u2014 A comparative study","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2016.09.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}